• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Atom Therapeutics Initiates Phase 2 Trial Of ABP-745 For ASCVD

    PHARMIWEB

    Atom Therapeutics Unveils Gout Therapy Partnership Prospects

    BUSINESSWIRE

    Atom to Present Positive Gout Drug Data at ACR Convergence 2025

    BUSINESSWIRE

    Atom Therapeutics Begins Ph 2 of ABP-745 for Acute Gout Flares

    BUSINESSWIRE

    Atom Therapeutic Join Gout Education Society on Gout Awareness Day

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.